ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SVCT Seneca Growth Capital Vct Plc

54.00
0.00 (0.00%)
10 Oct 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Seneca Growth Capital Vct Plc LSE:SVCT London Ordinary Share GB00BG13MH08 B ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 54.00 52.50 55.50 54.00 54.00 54.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty -2.19M -2.67M -0.0840 -6.43 17.17M

Seneca Growth Capital VCT plc Net Asset Value(s)

31/03/2021 7:00am

UK Regulatory


 
TIDMHYG TIDMSVCT 
 
 
   Net Asset Value(s) 
 
   Seneca Growth Capital VCT Plc (the "Company") 
 
   31 March 2021 
 
   Net asset value ("NAV") update for the period ended 29 March 2021 
 
   The Directors and the Investment Manager of the Company, Seneca Partners 
Limited ("Seneca"), have reviewed the valuation of the Company's 
portfolios as at 29 March 2021. 
 
   Ordinary Shares 
 
   As at 29 March 2021, the unaudited NAV of an Ordinary share was 42.8p 
per share. This is a decrease of 1.2p from the previously published 
unaudited NAV as at 19 February 2021 of 44.0p and is due to the change 
in value of the Ordinary share pool's quoted investment Scancell 
Holdings Plc, net of the associated performance fee. As at 29 March 
2021, shares in Scancell Holdings Plc were valued at 23.5p (19 February 
2021: 24.5p). The Directors also reviewed the unquoted investments held 
in the portfolio and concluded that all valuations remain appropriate. 
 
   No further disposals have been made in the period since the post balance 
sheet events included in the 31 December 2020 Annual Report. 
 
   B Shares 
 
   The unaudited NAV of a B share as at 29 March 2021 was 100.4p per B 
share. This is an increase of 1.0p from the previously published 
unaudited NAV as at 19 February 2021 of 99.4p and is due to changes in 
the value of the quoted investments and the impact of ordinary running 
costs incurred in the period. The Directors also reviewed the unquoted 
investments held in the portfolio and concluded that all valuations 
remain appropriate. 
 
   The B share pool made one additional investment in the quarter since the 
post balance sheet events included in the 31 December 2020 Annual 
Report. On 1 March 2021, the Company's B share pool invested GBP400,000 
in Evgen Pharma Plc alongside Seneca's EIS Portfolio Service. 
 
   For the purposes of calculating the unaudited net asset value per share, 
quoted investments are carried at closing bid prices as at 29 March 2021 
and unquoted investments are carried at fair value as at 29 March 2021 
(fair value as determined by Seneca in the case of the B share portfolio 
and by the Directors in the case of the Ordinary share portfolio). 
 
   The number of B shares in issue at 29 March 2021 was 9,916,062 and the 
number of Ordinary shares was 8,115,376. 
 
   This announcement contains inside information as stipulated under the UK 
version of the Market Abuse Regulation No 596/2014 which is part of 
English law by virtue of the European (Withdrawal) Act 2018, as amended. 
On publication of this announcement via a regulatory information service, 
this information is considered to be in the public domain. 
 
   The Offer by the Company has closed for the 2020/21 tax year but remains 
open for the 2021/22 tax year. 
 
   For further information, please contact: 
 
   John Hustler, Seneca Growth Capital VCT Plc at 
https://www.globenewswire.com/Tracker?data=5MxfgVB5DtxBEhcglwUxsMZBbvxkrCM-33Fc2viI4nyiubmjlTnwNzm8yEls2-r6Lv4f-ZonNwbcOCatlhWk_mHlJOcjCf-2uSa1OvrDI83NsiDuCHaq6pwZAZtHIaPUZbNwdmYq-JygI93lxwrvpfbsd_xFnPzyZk7RTcOuINGvdCnHTN2vpbpCJL7XYnlRYUK7-jtL1PmGnoQH1VwaMOeaRRVhGKSfnLV-Iy0fXK-rFrLyWsAfTOFEDQhOoTKMJZb4X4FCIEA6O2Pl-Ls8tELC5CTHfnc2HZdTiz7_Ljg= 
john.hustler@btconnect.com 
 
   Richard Manley, Seneca Growth Capital VCT Plc at 
https://www.globenewswire.com/Tracker?data=6_a4z6dfRFnMvSi_WTwogEboBSEjYE3CfilbWfK1GcjhEzOMAnIEdA7s-YHJR73yscGV5_WNCiJNqI-GDrdaYbnxCA-XZqYwRee5WJtrXW3DBJx1JCtfFoit2fRLAZMGl3ByAOeIQ3gU7KYbXtso1DA3TryaiuyGHgocwmhHouQAScGXCg--icmECIYeKsz3i21lQ5YWb16zspFkxDX2u1QcCX2BAbmcIb6v1Wd18N7tifVey_1ZTJKIYuVGEJM2NEyhiChg1onLx3Kf8IZbg-ScRaD0L0xkq-OkvjXPvOO9zbnORsHqVmvimLx74YIZM_3fzzv2DAozXHjUES2lsw== 
Richard.Manley@senecapartners.co.uk 
 
   Any enquiries regarding the offer for subscription of B shares should be 
directed to: 
 
   John Davies at Seneca Partners Limited on 01942 295 981 or at 
https://www.globenewswire.com/Tracker?data=sagEx1ioSa9VrSsFR756ENk4bpYlnZhjnyQ1CAUFFzMATvtcY_Oze8zAvy5Q2bqfVKSxHEmiBUX5ab-nzZGUgGXQG6tU3hNqsg-FFbA-i1FyRBu3iZBE9OGNhHIkbmspjr6SF0UfdgsIhdGRGOghWiu9z-Dvd2yotDIY2a5o7P-4GXVnSmVVSAj_gGJRFy_MCsJjXSFJuPIFFrYu2npjlZp7ySmLZMGorIvLbARl-BjaTYRklUBGHsmDhx_wQnLbqtUhDO_3abI-n7Xc-x87HAb4PIk8_uU6yYKX2TWpOxGPsodNg6-H1RUOMMgdR3GD 
John.Davies@senecapartners.co.uk 
 
 
 
 

(END) Dow Jones Newswires

March 31, 2021 02:00 ET (06:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Seneca Growth Capital Vct Chart

1 Year Seneca Growth Capital Vct Chart

1 Month Seneca Growth Capital Vct Chart

1 Month Seneca Growth Capital Vct Chart

Your Recent History

Delayed Upgrade Clock